leflunomide has been researched along with Cogan Syndrome in 1 studies
Leflunomide: An isoxazole derivative that inhibits dihydroorotate dehydrogenase, the fourth enzyme in the pyrimidine biosynthetic pathway. It is used an immunosuppressive agent in the treatment of RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.
leflunomide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 5-methyl-1,2-oxazole-4-carboxylic acid with the anilino group of 4-(trifluoromethyl)aniline. The prodrug of teriflunomide.
Cogan Syndrome: A condition consisting of inflammatory eye disease usually presenting as interstitial KERATITIS, vestibuloauditory dysfunction, and large- to medium-vessel vasculitis.
Excerpt | Relevance | Reference |
---|---|---|
"We present a case of Cogan's syndrome remission associated with leflunomide (LEF) in a juvenile patient." | 1.35 | Leflunomide for the successful management of juvenile Cogan's syndrome. ( Bao, X; Cai, Y; Cao, L; Xie, L, 2009) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Xie, L | 1 |
Cai, Y | 1 |
Bao, X | 1 |
Cao, L | 1 |
1 other study available for leflunomide and Cogan Syndrome
Article | Year |
---|---|
Leflunomide for the successful management of juvenile Cogan's syndrome.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Sedimentation; Child; Cogan Syndrome; Drug Therapy, C | 2009 |